Older people suffering from cancer to treble by 2040

By Admin
Macmillan Cancer Support states that the number of older people living with cancer will treble by 2040 from 1.3 million in 2010 to 4.1 million. In 2040...

Macmillan Cancer Support states that the number of older people living with cancer will treble by 2040 from 1.3 million in 2010 to 4.1 million. In 2040, 23% older people will have had a cancer diagnosis in 2040, which is almost double the proportion in 2010, said the new Macmillan-funded research by King’s College London.

This is nearly four times the proportion for people between 45 and 64. Meanwhile, the lung cancer occurrences in the older women will more than double from in 2010 to 2040.

The research also said the prevalence of lung cancer in older men is expected to decrease. According to the research, the sharp rise cancer prevalence is likely to be due to reasons like the increasing incidence and increasing cancer survival and ageing population.

Professor Henrik Moller, one of the study authors at King’s College London says, “The research shows that large increase can be expected in the oldest age groups in the coming decades and with this the rising demand on the health services.”

The research also states, older cancer patients face many barriers to get the best care and treatment.

Macmillan Cancer Support is the largest British charities. It provides specialist health care information and financial support to the people suffering from cancer. The British charity supports cancer support groups, local information and support centres and also helps with practical, medical, financial and emotional support.

Share
Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma